Science Explorer Interactive view Map
Company · Hyderabad · India

Novartis (India)

In research, Novartis (India) stands highest in Medicine (#8,010 of 10,443 worldwide) and Health Sciences (#9,839 of 11,982 worldwide), 2022–2025.

novartis.inROR OpenAlex
World rank, 2022–2025
#16,575
of 28,054 · #22,174 all time
Rank in India
#1,127
of 1,840
Research works
379
▲ 58% vs 2013–17
Citations
4.5k
11.8 per fractional work
Top-10% rate
13.8%
record average 16.5%
Open access
50%
world 28%

What is Novartis (India) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #8,010 of 10,443 14.1%77 #10267
Health SciencesDomain #9,839 of 11,982 13.9%80 #13084

Each strip is that field’s whole ranked pool, with the notch where Novartis (India) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.23× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.96× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 4.94× its world share, 6 worksImmunology and Micro…Neuroscience: 0.75× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.31× its world share, 4 worksPharmacology, Toxico…Chemistry: 1.79× its world share, 4 worksChemistryComputer Science: 0.39× its world share, 4 worksComputer ScienceEarth and Planetary Sciences: 0.10× its world share, 0 worksEarth and Planetary …Engineering: 0.13× its world share, 2 worksEngineeringEnvironmental Science: 0.20× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.39× its world share, 2 worksMaterials ScienceMathematics: 1.17× its world share, 2 worksMathematicsPhysics and Astronomy: 0.01× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.72× its world share, 2 worksHealth ProfessionsMedicine: 3.10× its world share, 77 worksMedicineNursing: 0.13× its world share, 0 worksNursingVeterinary: 0.95× its world share, 0 worksVeterinaryArts and Humanities: 0.06× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.06× its world share, 0 worksBusiness, Management…Decision Sciences: 0.93× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 3.59× its world share, 10 worksEconomics, Econometr…Psychology: 0.07× its world share, 0 worksPsychologySocial Sciences: 0.18× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.3×. Every wedge is a field page.

Who are the top researchers at Novartis (India)?

Ranked on the composite score, Harneet Kaur lead among researchers whose main affiliation is Novartis (India).

  1. 1 Harneet Kaur India · #809,164 worldwide 82 citations · 30 works
All ranked researchers at Novartis (India)

Which keywords describe research at Novartis (India)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Clinical Trials, Autoantibodies, Diagnosis, Economic Evaluation, Cost-effectiveness Analysis, Health Utility Measures and Mutation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life11▲ 5.7×11 topics
  2. Epidemiology9▲ 1.69×41 topics
  3. Inflammation8▲ 2.9×25 topics
  4. Clinical Trials8▲ 8.6×11 topics
  5. Diagnosis7▲ 5.6×17 topics
  6. Autoantibodies7▲ 22×7 topics
  7. Cost-effectiveness Analysis6▲ 50×1 topic
  8. Economic Evaluation6▲ 35×2 topics
  9. Health Utility Measures6▲ 50×1 topic
  10. Management5▲ 5.3×12 topics
  11. Mutation5▲ 20×3 topics
  12. Treatment5▲ 3.1×20 topics
  13. BCR-ABL5▲ 132×1 topic
  14. Imatinib5▲ 132×1 topic
  15. Prognostic Factors4▲ 7.6×6 topics
  16. Autoimmune4▲ 59×2 topics
  17. Genetics4▲ 4.0×11 topics
  18. Thrombosis4▲ 9.9×5 topics
  19. Immunosuppressive Therapy3▲ 14×7 topics
  20. Chronic Spontaneous Urticaria3▲ 113×1 topic
  21. Urticaria3▲ 113×1 topic
  22. Precision Medicine3▲ 5.2×7 topics
  23. Cognitive Impairment3▲ 8.8×3 topics
  24. Diagnostic Criteria3▲ 10×4 topics
  25. Breast Cancer3▲ 9.0×4 topics
  26. Hematopoietic Stem Cells3▲ 25×3 topics
  27. Rituximab3▲ 14×4 topics
  28. Glomerular Diseases3▲ 62×1 topic
  29. Medication Adherence3▲ 38×2 topics
  30. Nephrotic Syndrome3▲ 62×1 topic
  31. Adverse Drug Reactions2▲ 36×2 topics
  32. Cardiovascular Disease Prevention2▲ 22×2 topics
  33. JAK2 Mutation2▲ 83×1 topic
  34. Multiple Sclerosis2▲ 51×1 topic
  35. Myelofibrosis2▲ 83×1 topic
  36. Neuromyelitis Optica2▲ 51×1 topic
  37. Cytokines2▲ 6.7×4 topics
  38. AML2▲ 35×1 topic
  39. Acute Myeloid Leukemia2▲ 35×1 topic
  40. Pharmaceutical Industry2▲ 46×2 topics

Which research topics does Novartis (India) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Chronic Myeloid Leukemia Treatments, Urticaria and Related Conditions and Renal Diseases and Glomerulopathies.

Health Systems, Economic Evaluations, Quality of Life: 6 fractional worksChronic Myeloid Leukemia Treatments: 5 fractional worksUrticaria and Related Conditions: 3 fractional worksRenal Diseases and Glomerulopathies: 3 fractional worksMultiple Sclerosis Research Studies: 2 fractional worksMyeloproliferative Neoplasms: Diagnosis and Treatment: 2 fractional worksAcute Myeloid Leukemia R…2Acute Myeloid Leukemia Research: 2 fractional worksCoagulation, Bradykinin, Polyphosphates, and Angioedema: 2 fractional worksComplement system in diseases: 2 fractional worksPharmaceutical Economics and Policy: 2 fractional works
Economics and EconometricsHematologyRheumatologyNephrology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 6 works
  2. 2 Chronic Myeloid Leukemia Treatments Hematology 5 works
  3. 3 Urticaria and Related Conditions Rheumatology 3 works
  4. 4 Renal Diseases and Glomerulopathies Nephrology 3 works
  5. 5 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
  6. 6 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
  7. 7 Acute Myeloid Leukemia Research Hematology 2 works
  8. 8 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 2 works
  9. 9 Complement system in diseases Immunology 2 works
  10. 10 Pharmaceutical Economics and Policy Economics and Econometrics 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.0%not open50.0%

World: 28% of research is openly available.

with international co-authors74.2%domestic only25.8%

World: 19% is written across borders.

How has Novartis (India)'s research output changed?

Output in 2018–2022 was 58% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Hyderabad

All research institutions in Hyderabad

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.